Fact CheckerSign in

NCT04532424Recruiting

Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

Source: ClinicalTrials.gov · Last updated 19 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Investigating the efficacy of a form of TMS called theta-burst stimulation for restricted and repetitive behavior in ASD.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
67 (estimated)
First submitted
21 Aug 2020
Start date
4 Jan 2021
Primary completion date
1 Dec 2029
Lead sponsor
Stanford University
Diseases
Autism
NCT number
NCT04532424

What you commit to

  • Study type: Interventional
  • Planned participants: 67
  • From 4 Jan 2021 to the primary completion date, 1 Dec 2029
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Any contraindications for TMS e.g. history of seizures other than clear substance-induced/fever-induced seizures with neurologist note or normal clean EEG and no seizure in at least 12 months prior to enrollment.
  • Currently taking Clozapine or another medication that the PI determines increases the risk of TMS or may disrupt the efficacy.

Other illness

  • Any current or past history of any physical condition which in the investigator's opinion might put the subject at risk or interfere with study results interpretation.
  • DSM-5 diagnosis of bipolar disorder or a psychotic disorder e.g. schizophrenia.
  • Conditions that increase the risk for COVID-19 (in accordance with university guidelines).

Other

  • Pregnancy.
  • Active substance use (\<1 week) or intoxication verified by toxicology screen--of cocaine, amphetamines, benzodiazepines.
  • Showing symptoms of withdrawal from alcohol or benzodiazepines.
  • Significant sensory impairments such as blindness or deafness.
  • Current severe insomnia (must sleep a minimum of 4 hours the night before stimulation).
  • Not willing to cooperate with the TMS procedures.
  • A motor threshold that is too high to allow safe/tolerable treatment.

Who the study is looking for

  • Diagnosis of Autism Spectrum Disorder (ASD)
  • Meet criteria for Autism Spectrum Disorder (ASD) on clinical assessments (ADOS-2 or CARS if conducted remotely \& ADI-R)
  • Aged between 12-45 years old
  • Have a reliable informant who can complete relevant questionnaires
  • Have DARB scores which indicate high levels (50% or above) of RRB on one of the following domains: Insistence on Sameness, Obsessive Compulsive Behaviors, and Unusual Interests

Age in the registry: 12 years to 45 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Stanford University
Coordinator of this site? Confirm its status
StanfordUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.